Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bristol-Myers Squibb and Karo Bio to codevelop new therapies for metabolic disorders

Oct. 15, 1997

Nonthiazolidinediones for diabetes and obesity described by Merck & Co.

Oct. 14, 1997

Heterocyclic compounds from Zeneca for hypercholesterolemia

Oct. 14, 1997

Gonal-F approved for marketing in U.S.

Oct. 13, 1997

Cambridge NeuroScience awarded sixteenth SBIR grant

Oct. 13, 1997

Roussel Uclaf develops estrogenic compounds

Oct. 9, 1997

FDA panel recommends approval of new uterine thermal ablation system

Oct. 8, 1997

Idoxifene progresses to phase III for osteoporosis

Oct. 8, 1997

Geref cleared for pediatric growth disorders in U.S.

Oct. 8, 1997

Antihyperlipidemic/antidiabetic agents reported by Otsuka

Oct. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...